Skip to main content
. 2021 Feb 12;10:547683. doi: 10.3389/fonc.2020.547683

Figure 1.

Figure 1

MPSSS inhibits lymphangiogenesis in tumor-bearing mice. CRC tumor-bearing mice were injected with PBS and MPSSS (30 µg/kg) intraperitoneal every day. Vectra was used to take photos of sections after IF staining (A). The fluorescence intensity of LYVE-1 was represented by pixels with InForm software (B). The data were recorded as the mean ± SD and analyzed by t-test. MP is short for MPSSS. (***p < 0.001).